Drug’s effectiveness for neurosarcoidosis studied

A drug commonly prescribed for Crohn’s disease and rheumatoid arthritis is also effective for treating neurosarcoidosis, according to new research led by Vanderbilt neurologists.

Sarcoidosis research, patient care focus of newly created center

Vanderbilt University Medical Center (VUMC) has established a Sarcoidosis Center of Excellence under the direction of Wonder Drake, M.D., associate professor of Medicine and Pathology, Microbiology and Immunology.

ResearchMatch database includes sub-registry for rare sarcoidosis

All ResearchMatch volunteers who self-report as having sarcoidosis will be prompted to answer additional questions to enhance the matching of volunteers with research teams who are studying this condition.

A path to sarcoidosis treatment

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

Sarcoidosis research finds promising oral therapy

VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control.

Bacterial signals in sarcoidosis

Study adds evidence for infectious agents’ role in sarcoidosis, an inflammatory condition that can lead to respiratory failure and death.